Metabolite-content (MC) refers to all small molecules which are the products or intermediates of metabolism within an organism. The metabolite-contents of plants which involve numerous secondary metabolites are highly related to their nutritional and medicinal features. Previous researches have confirmed that phylogeny-guided approaches have been seen as one of the timeefficient and informative approaches to plant-based drug discovery. However, the phylogenetic reconstruction of plants is not determined conclusively from genomic sequence data. Here, we investigate the systematic value of metabolite-contents of plants, especially the predictive power of metabolite-content data in exploration of edible and medicinal properties for bioprospecting. In this study, we reconstructed the phylogenetic tree for a set of plants which are distributed in different genera and families by their metabolite-content data obtained from KNApSAcK Core DB. We used a network based approach to abstract structurally similar metabolites as features, and measure the phylogenetic distance by a binary method. We also reconstructed phylogenetic trees based on plastid markers rbcL, matK and ITS2 for the same set of plants, to investigate the predictive power of these two approaches, sequence-and MC-based approaches, in guiding the prediction of medicinal/edible properties.
Introduction
Plants are the major contributors of natural products and are usually rich in nutritional or medicinal properties, which are attributed to the complex secondary metabolite constituents of them [1] [2] [3] . Plants are an important source of novel pharmacologically active compounds with many pharmaceutical drugs have been derived directly or indirectly from plants, and have played a central role in human health-care since ancient times [4] [5] [6] . Many pharmaceutical drugs are derived from plants that were first used in traditional systems of medicine [6] . According to the World Health Organization, about 25% of medicines are plant-derived [2] .
Discoveries of novel molecules and advances in production of plant-based products have revived interest in natural product research [7, 8] . The number of traditionally used plant species worldwide is estimated to be between 10,000 and 53,000; however, only a small proportion have been screened for biological activity [9] [10] [11] , and the plants from some regions are less studied than others. Moreover, the potential of plants to yield new valuable drugs is under threat due to the alarming bio-diversity loss, with recent estimates indicating that every fifth plant species on earth is threatened with extinction [12] . Therefore; there is an urgent need for a time-efficient and systematic approach for unlocking the potential of plants in drug discovery.
A correlation between phylogeny and biosynthetic pathways could offer a predictive approach enabling more efficient selection of plants for drug discovery. Following the assumption that plantderived chemicals are constrained to evolutionary plant lineages, phylogeny-guided approaches have been seen as one of the timeefficient and informed approaches to plant-based drug discovery [13, 14] .A series of studies have been conducted and verified that phylogeny is an efficient tool to facilitate drug discovery for diverse genera across different regions or cultures [13] [14] [15] [16] [17] [18] . However, most of these studies focused on only a small cluster of genera, which limits its practical application. This approach also faces the limitation of incomplete sequence data. Moreover, phylogenetic distance correlated to feature similarity of species will also be invalid once beyond a certain threshold [19] . Therefore, a special perspective different from sequence-based phylogeny is valuable for understanding the evolution of bioactive features and facilitating the prediction and discovery of medicinal properties in plants.
Besides molecular biology which is in the view of nucleotide sequence comparison, metabolite feature is also closely related to the evolution of pathways for both primary and secondary metabolites. Many researchers have begun to explore phylogenetic distance between species from the diversity of metabolite features, either alone or in combination with sequence features. Clemente et al. (2007) presented a method for assessing the structural similarity of metabolic pathways for several organisms and reconstructed phylogenies that were very similar to the National Center for Biotechnology Information (NCBI) taxonomy [20] . Borenstein et al. (2008) predicted the phylogenetic tree by comparing the "seed set" of metabolic networks [21] . Mano et al. (2010) considered the topology of pathways as chains and used a pathway-alignment method to classify species [22] . Chang et al. (2011) proposed an approach from the perspective of enzyme substrates and corresponding products in which each organism is represented as a vector of substrate-product pairs. The vectors were then compared to reconstruct a phylogenetic tree [23] . Ma et al. (2013) demonstrated the usefulness of the global alignment of multiple metabolic networks to infer the phylogenetic relationships between species [24] . A. A. Abdullah et al. (2015) classified microorganism species based on the volatile metabolites emitted by them, and the results have been well explained in terms of their pathogenicity [25] . However, most of these studies have focused on microorganisms such as archaea, and only a few studies have involved land plants and the bioactive compounds produced by them.
The systemization of plants on the basis of their chemical constituents, which is also known as plant chemosystematics, could be helpful in solving taxonomical problems and exploring nutritional and medicinal properties from plants. Traditional chemosystematics of plants is based on the presence of selected metabolites. The incomplete data of metabolite constituents of plants limits its ability to solve taxonomical problems and discover new natural products or medicinal properties from plants [26, 27] . To perform a holistic review on the metabolite features of a species, we propose the concept of metabolite-content. Metabolite-content refers to all small molecules which are the products or intermediates of metabolism within an organism. It differs from metabolome in that the metabolite-content focuses on the qualitative collection of small metabolites and ignores the quantitative differences, which is instable with different parts and stages of one organism.
The secondary metabolite constituents of a plant are highly related to its pathways which are constrained to evolutionary phylogeny, and also related to the bioactive compounds of the plant which determine the medicinal and nutritional features of it [26] . Comparative classification of plants based on their metabolitecontent-similarity could be used to explore the evolutionary and bioactive relation between them [28] . Here, we investigate the phylogenetic value of metabolite-content data, especially the predictive power of metabolite-content data in exploration of medicinal and edible plants for bioprospecting, using the KNApSAcK Core DB.
The KNApSAcK Core DB is an extensive plant-metabolite relation database that can be applied in multifaceted researches of plants, such as identification of metabolites, construction of integrated databases, bioinformatics and systems biology [29] [30] [31] [32] , and can be considered an advanced source of metabolite-content data of plants. The KNApSAcK Core DB contains 111,199 speciesmetabolite relationships that encompass 25,658 species and 50,899 metabolites, and these numbers are still growing [30] .
In this paper, we reconstructed the phylogenetic tree for a set of plants which are distributed in different genera and families by their metabolite-content data obtained from KNApSAcK Core DB. We used a network based approach to abstract structurally similar metabolite groups as features, and measure the phylogenetic distance by a binary method. We also reconstructed the phylogenetic tree based on common DNA barcodes for a subset of plants, to investigate the predictive power of these two approaches, sequence-and metabolite-content-based method, in guiding the prediction of medicinal/edible plants for bioprospecting.
Material and Methods

Dataset and Preliminaries
The input metabolite-content data are species-metabolite relationships obtained from the KNApSAcK Core DB, which is a part of the KNApSAcK Family DB [30] . The KNApSAcK Core DB contains most of the published information about speciesmetabolite relations, but this is obviously far from complete regarding plants and other living organisms. We removed the plants with inadequate plant-metabolite relations to guarantee that the amount of metabolite-content of selected plants is sufficient enough to reveal their interrelations. The KNApSAcK Core DB also provides MOL molecular structure files for the metabolite compounds. We used R package ChemmineR (v2.26.0) to generate atom pair fingerprints from molecular structure description files [33] . And these molecular fingerprints were used to measure the structural similarity for all the metabolite pairs.
In this study, we also reconstructed phylogenetic tree for the same plant samples we used before based on three common DNA barcodes: two chloroplast barcodes rbcL and matK, and one nuclear barcode ITS2. The DNA sequence data are collected from GenBank [34] , and certainly there is lack of data for some plants. 
Phylogenetic Hypothesis
In this study, we produce phylogenetic hypothesis for each groups of samples by compiling DNA sequence data from the plastid markers rbcL, matK and nuclear markerITS2 respectively. The sequence data of rbcL, matK and ITS2 are aligned by Clustal X 2.0 to compensate the missing and gapping data. Bayesian analyses of each sample groups were performed with MrBayes v3.2 [35, 36] . We produced Bayesian phylogenetic hypothesis using the model (Parameters: lset NST = 6 RATES = gamma). For each group we perform the analysis with more than 1,000,000 generations. The average standard deviation of the split frequencies (i.e., the average of all standard deviations of all observed splits between two independent analyses from different random trees) is down to <0.05 after the analysis is finished.
Clustering of Plants Based on Metabolite-Content Similarity
For classifying plants based on currently available metabolitecontent data, firstly we need an approach that can compensate for the limitations of missing data. Adjacent metabolites along a metabolic pathway are often related to similar substructures, and structurally similar metabolites are involved in the same or similar pathway. Therefore, plants that share highly structurally similar metabolites are likely to be within the same category and represent similar bioactivity. In this study, we linked plants to structurally similar metabolite groups instead of individual metabolites.
We used the Tanimoto coefficient to measure the structural similarity between two metabolites and constructed a network of metabolites based on chemical structure similarity [37] . The Tanimoto coefficient between two metabolites and is defined as follows, which is the proportion of the features shared by two compounds divided by their union:
The variable AB is the number of features common in both compounds, while A and B are the number of features that are related to the respective individual compounds. The Tanimoto coefficient has a range from 0 to 1 with higher values indicating greater similarity than lower ones. The Tanimoto coefficient can be calculated from molecular fingerprints using the R package ChemmineR [33] . Empirically, a Tanimoto coefficient value larger than 0.85 indicates that the compared compounds represent highly similar bioactive features [38] . We used 0.85 as the threshold to insert an edge between two metabolites and constructed a network of metabolites. For this network we applied a graph-clustering algorithm DPClus to generate metabolite groups that contains structurally similar compounds.
The DPClus algorithm is a graph-clustering algorithm that can be used to extract densely connected nodes as a cluster [39, 40] . This algorithm can be applied to an undirected simple graph = ( , ) that consists of a finite set of nodes and a finite set of edges . Two important parameters, density and cluster property cp, are used in this algorithm. Density of any cluster is the ratio of the number of edges present in the cluster (| |) to the maximum possible number of edges in the cluster (| | max ). The cluster property of a node with respect to cluster is represented as Where • is the number of nodes in and is the total number of edges between and each node of .
By DPClus algorithm the metabolites were divided into many groups such that each group contains structurally similar compounds and can be treated as a distinctive pattern of structure. A plant is related to a metabolite group if it is related to any metabolite in the group. The original plant-metabolite relations are transformed into plant versus metabolite-group relations. We used such groups to measure the similarity between plants, thus reducing the effects of incomplete metabolite-content data. Each plant could be represented as a binary vector which is comprised of p variables with values 1 or 0 indicates presence or absence of each metabolite group. The metabolite-content-similarity of two plants was calculated by Simpson similarity coefficient as follow,
Here,
• , , and are the frequencies of the events & ,
, and & , respectively [41] [42] [43] . We transformed a similarity coefficient, , to a distance coefficient, , by the transformation = 1− and classified the plants by using Ward's hierarchical clustering method using R.
Thus for each of the three sample groups (172 samples with data of gene rbcL, 165 samples with data of gene matK, 160 samples with data of gene ITS2), we can reconstruct the phylogenetic trees by sequence data and metabolite-content data. To evaluate the power of the sequence data and the metabolite-content data in predicting medicinal/edible properties in the context of these three sample groups, we reconstructed phylogenetic trees by similarity of corresponding gene sequence and similarity of metabolitecontent data respectively, and performed comparative analysis for these two types of phylogenetic trees.
Phylogenetic and Statistical Analyses
We assessed the relationship of phylogeny with the medicinal/edible properties by calculating the phylogenetic signal of medicinal/edible plants. We investigated the strength in phylogenetic signal of medicinal/edible plants using the D statistic, a measure of phylogenetic signal, implemented by the function phylo.d in the R package caper [44, 45] . D is calculated as follows, Where is the observed number of changes in the binary trait (medicinal/edible properties) across the ultrametric phylogeny, is the mean number of changes generated from 1000 random permutations of the species values at the tips of the phylogeny, and is the mean number of changes generated from 1000 simulations of the evolution for the character by a Brownian motion model of evolution with likelihood of change being specified as that which produces the same number of tip species with each character state as the observed pattern.
The D statistic generates a value that usually lies between 0 (indicates the trait is highly correlated with phylogeny) and 1 (indicates the trait has evolved in essentially a random manner). 
Evolutionary Patterns of Medicinal Properties
To narrow down the number of species chosen for an early stage of medicinal/edible plant discovery screening, we identified the position of phylogeny clustering for medicinal/edible properties. We highlighted such hot nodes (nodes that encompass significantly more medicinal/edible plants than the rest of the tree) by using the "nodesig" command in PHYLOCOM v4.2for all of the phylogenetic trees [46] . This option was used to determine the position of phylogenetic clustering in a community sample by testing each node of the phylogenetic tree for overabundance in medicinal/edible terminal taxa distal to it. Observed patterns for each phylogenetic tree were compared with those for random samples of the same size per case, drawn from the phylogeny.
For these hot nodes in each of the phylogenetic trees we obtained, we recorded the percentage of the total and medicinal/ edible properties included in them. We compared the observed number of medicinal/edible plants encompassed in the hot nodes to the one expected to be found randomly in the percentage of the plants encompassed in the hot nodes; this was the gain in percentage of medicinal hits compared with random.
Results and Discussion
All of the sequence data were downloaded from GenBank (Table 1) . It should be noted that not all samples have complete sequence data ( Table 2 ). The ubiquitous missing and incomplete sequence data indicates that now the sequence data of plants included in GenBank are far from covering most of the plants, especially wild plants that not have been fully explored by human. The KNApSAcK speciesmetabolite relation database is also far from complete with a large amount of data fragmentations. However, the plants with abundant metabolite-content data included in KNApSAcK database are frequently inconsistent with plants with complete sequence data included in GenBank. The metabolite-content data of plants in KNApSAcK could be seen as a necessary supplement of sequence data in GenBank for facilitating the analysis of evolutionary relations between plants and guiding the prediction of medicinal/edible plants since the plants covered by these two databases are complementary to each other. The plant samples selected in our research are performing both adequate sequence and metabolite-content data with acceptable data missing. Thus, we could investigate the effect of these two types of data in extracting medicinal/edible patterns from the same plant samples. We reconstructed the phylogenetic trees for the three sample groups by corresponding sequence data and metabolite-content data respectively (Figure 2 ). Caesalpinia crista *KP094390.1 *EU361900.1 T The uses information of plants was collected from published literature and online sources, and annotated as seven categories: edible plants, medicinal plants, medicinal/edible multi-useful plants, landscaping plants, timber plants, poisonous plants and wild plants (Table 3) . We investigated the strength in phylogenetic signal of medicinal and edible categories for each phylogenetic tree we obtained using the D statistic (Table 4) . We found that plants with medicinal/edible uses are significantly clustered in metabolite-content-based phylogenetic trees of all the three sample groups. The rbcL-and matK-based trees also show moderate phylogenetic signal for medicinal/ edible plants but much weaker than that in metabolite-content-based trees. The ITS2-based tree shows weak phylogenetic signal for both medicinal and edible plants. Generally, the edible plants are more phylogenetically clustered than medicinal plants in all the three sample groups for both of the two approaches, with lower D estimate values and higher P(D>0) values. This suggests that comparing with edible plants, the distribution of medicinal plants across the lineages reveals some but less phylogenetic relations. The mechanism of medicinal plants is much subtler than edible plants and is related to the expression of small secondary metabolites which are sometimes randomly distributed along the clades. Moreover, the expressions of the secondary metabolites with medicinal bio-activity are more closely related to the overall metabolite features, i.e., metabolite-contents of the plants. The plants with similar metabolite-contents tend to have similar medicinal features, and such observations are more obvious comparing with sequence-based approach in our experiments. Thus we might found more phylogenetic patterns by skipping gene data and comparing metabolite-content data directly. Considering the gene data available from GenBank is usually incomplete, the metabolite-content data implies great potential applications in predicting medicinal properties. As a tentative approach to narrow down the number of medicinal/edible plants selected for bioprospecting, we also identified the hot nodes that are significantly overrepresented by species of medicinal/edible uses (Table 5 ). We can observe that phylogenetic clustering was found for edible and medicinal plants in all of the tested phylogenetic trees except ITS2 sequence-based tree. The hot nodes in metabolite-content based phylogenetic trees tend to encompass more medicinal and edible plants than sequence-based phylogenetic trees. This suggests that comparing with sequence-based approach it is more effective to explore phylogenetic patterns for medicinal and edible plants with the metabolite-content-based approach. We also compare the observed patterns for edible and medicinal plants with those for random samples of the same size drawn from the phylogenies. For these hot nodes in each of the tested phylogenetic trees, we recorded the percentage of edible and medicinal plants included in them. We compared the observed number of medicinal/edible plants encompassed in the hot nodes to the one expected to be found randomly in the percentage of the plants encompassed in the hot nodes, and this was the gain in percentage of medicinal/edible hits compared with random. The phylogenetic distribution of medicinal and edible plants encompassed by hot nodes also shows that the edible plants perform more converge trends and gains in percentage of hits. This indicates that the edible features of plants are more closely associated with the phylogeny as well as the metabolite-content similarity, and also suggests that there may be many unexplored medicinal properties within the plant kingdoms. Moreover, we also investigated the coincidence rates of the medicinal/edible plants encompassed by hot nodes between the sequence-based and metabolite-content-based phylogenetic trees. We found that there is not significantly coincidence of medicinal plants encompassed by hot nodes of these two types of phylogenetic trees. In other words; the medicinal patterns identified by metabolite-content-based approach shows no significant similarity to the medicinal patterns identified by sequence-based approach. Our findings thus indicate that the metabolite-content-based approach might highlighted different group of medicinal plants with sequencebased approach, and might reflect more unexplored medicinal potential not associated with the sequence-similarity.
As a meaningful attempt, we imported more plant-metabolite relation data (28123 plant-metabolite relations associated with 1047 plants) and reconstructed phylogenetic tree by metabolite-content-similarity (Figure 3) 
Conclusion
Many researchers have proved that edible and medicinal plants were derived mostly from some lineages, and tend to be clustered rather than scattered in the phylogenetic tree. Our study reveals that besides the sequence data, metabolite-content data is also closely associated with medicinal and edible bioactivity of plants and can explore the medicinal/edible patterns in a different perspective from DNA sequence-based plant phylogeny.
We found that comparing with DNA sequence-based approach; our metabolite-content-based approach performs fair even better predictive power of medicinal properties. Moreover, the hot nodes of metabolite-content-based approach highlight different medicinal/ edible patterns comparing with DNA-sequence-based approach. This implies that metabolite-content-based approach could reflect unexplored medicinal/edible properties not recovered by the sequence-based approach.
Since sequence-based plant bioprospecting is frequently confined to the lack of DNA sequence data, it is rational to utilize metabolite-content data to extent the limitation of sequence-based bioprospecting. Metabolite-content-based plant phylogeny reconstruction could provide a new perspective in plant bioprospecting. With the improvement of metabolite-content database and the integration of various plant pharmacopoeia, such MC-guided bioprospecting approach can be further accelerated, and the predictive power for medicinal/edible plants will also be improved with the completeness of metabolite-content database in future.
